Aqara Previews New Smart Home Tech at IFA 2024
Aqara, a global leader and pioneer in IoT, today unveiled a selection of innovative solutions and technologies for the smart home focused on enhancing security, safety, energy efficiency, and interoperability globally; as well as new integration partnerships with Home Assistant and Tesla.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905190004/en/
Aqara Previews New Smart Home Tech at IFA 2024 (Photo: Business Wire)
The company is doubling down on home security and monitoring with the 4MP Camera Hub G5 Pro designed for outdoor use and equipped with True Color Night Vision; the Garage Door Controller T2 Kit for the smart control of up to two garage doors; and the Valve Controller T1 and Smoke Detector to protect properties from water and fire damage.
Committed to delivering smart home experiences with simplicity and enhanced interoperability, Aqara continues to expand its Thread product portfolio with an innovative approach to incorporate both Thread and Zigbee communication. The Company extents its European energy management product lineup with a new series of Thread-enabled wall switches, including the Light Switch H2 EU, Dimmer Switch H2 EU, and Shutter Switch H2 EU. The company is also adding to its smart lighting portfolio with the Thread-enabled LED Bulb T2 for everyday and atmospheric illumination. Additionally, Aqara will showcase new AI-powered voice capabilities with the Aqara Voice Mate H1, a battery-powered accessory that works with Hub M3 and allows interaction with Aqara Copilot.
Aqara continues to invest in Matter, through new capabilities and support across its product lineup and in its future roadmap, opening up a world of new possibilities for integration, automations and ambient control, and smart energy management. Aqara is showcasing these new products along with other advanced technologies and prototypes at IFA 2024 at Messe Berlin, in Hall 1.2, Stand 329.
Enhanced Security and Safety for the Home
Camera Hub G5 Pro – The Camera Hub G5 Pro is Aqara’s first surveillance camera developed for outdoor use. Available in PoE and Wi-Fi versions, the 4MP G5 Pro is equipped with True Color Night Vision and on-device AI capabilities that detect and recognize faces, vehicles, pets, and packages. These features help users monitor their properties in real time and deter potential intruders. Live and recorded videos are end-to-end encrypted, and its eMMC storage can sync to both cloud and local NAS servers. The G5 Pro features wide compatibility with major platforms such as Apple Home (including HomeKit Secure Video), Alexa, Google Home and SmartThings, and has added RTSP support to allow streaming to NVRs and video servers. A Zigbee 3.0 hub is built in to help connect the outside to the inside.
Garage Door Controller T2 Kit – With control for up to two sectional garage doors, the Garage Door Controller T2 Kit adds convenience and smart security to one of the most forgotten areas of the home: the garage. It integrates the garage as an access point which can additionally be monitored and controlled, providing users with an integral smart home experience. The garage can be accessed via geofencing, voice assistants, mobile apps, and automations, and the hassle-free wireless sensor helps homeowners monitor the garage door status in real time. This solution supports Alexa, HomeKit, Google Home, and other Matter-enabled platforms via a compatible Aqara hub, and it works seamlessly with other smart devices from either Aqara or other third-party brands.
Valve Controller T1 – The Valve Controller T1 can be integrated with leak detectors such as Aqara’s Water Leak Sensor, and automatically shut off one’s water or gas systems in response to a potential flood or gas leak, helping to safeguard the home even when no one is around. Compatible with lever and butterfly handle valves on DN15, DN20 and DN25 pipes, the Valve Controller T1 features a wireless, retrofit design to simplify the installation. No modification to the existing pipe or rewiring is required, making it friendly for DIY users.
Smoke Detector – Equipped with a powerful siren, the Aqara Smoke Detector triggers an alarm of up to 85 decibels at the first sign of smoke. It also triggers all siren-equipped Aqara hubs and other grouped smoke detectors throughout the home. Built upon the Zigbee protocol, the Smoke Detector boasts an ultra-long battery life of up to 10 years, minimizing maintenance.
Expanded Energy Management & Smart Lighting Lineup with Thread
H2 EU wall switches lineup – Expanding Aqara’s energy management product lineup in the European market, a new series of Thread-enabled wall switches is debuting, including the Light Switch H2 EU, Dimmer Switch H2 EU, and Shutter Switch H2 EU. With both Thread and Zigbee communication built in, users can opt for the Thread protocol to enjoy native Matter compatibility and seamless interoperability across platforms. Alternatively, users can opt for the wider feature set and benefits that Zigbee protocol provides, including power monitoring and decoupling the switch from light circuits so that the smart switch can be used with the smart lights. The H2 EU wall switches also feature innovative engineering that allows them to be used in both houses with or without a neutral wire, which simplifies the overall installation process for DIY users.
LED Bulb T2 – The Thread-enabled LED Bulb T2 expands Aqara’s robust smart lighting line. Available in both RGB CCT version that offers ultra-wide range of tunable whites (2000-9000K) and 16 million vibrant colors and the simpler CCT version, this new LED bulb creates the perfect ambiance at home with the crisp, high-quality white light for productivity and the soothing spectrum of colors available to set the mood. Equipped with Thread and Zigbee communication, the LED Bulb T2 caters to a wider range of smart home users with varying priorities, whether they prefer Thread for a future-proofing setup or Zigbee for the more mature, proven experience. The new T2 series includes E26, E27 and GU10 bulbs.
New Matter Capabilities & Integration Partnerships
Advanced Matter Bridging –The Hub M3 is rolling out the new Advanced Matter Bridging feature, which allows users to sync any conditions (“IF”) and actions (“THEN”) in the Aqara Home app to other third-party Matter apps. By configuring a Signal and a Scene, which is a sequence of IFs and THENs respectively, users can now expose those previously Aqara exclusive conditions and actions - for example the hand gesture recognition or camera auto-cruise activation - to their preferred platform and create more sophisticated home automation.
Home Assistant Partnership – Aqara announces its participation in the Work with Home Assistant program, offering optimized experiences to the vast Home Assistant users. The first Aqara devices that have been certified include the Hub M3, Smart Lock U200, and Motion and Light Sensor P2. More Aqara products are expected to receive certifications in the next months.
Tesla EV Integration – Tesla electrical vehicles (EVs) can now be integrated into Aqara Home automations, allowing users to automate their EVs or to integrate them into smart home routines. For example, charging the EV during off-peak hours when the electricity rates are lower, or being able to turn on the vehicle and start the in-car air conditioning when the coffee maker starts in the weekday morning.
Intuitive Home Interaction through Voice with Privacy A Priority
Voice Mate H1 – The Voice Mate H1 brings the ultimate convenience to the Aqara smart home system by enabling intuitive voice control without using a phone. This product is an accessory of the Aqara Hub M3, and is a highly compact, battery-powered device that has a microphone built-in, allowing users to command the Gen AI-enabled Aqara Copilot from anywhere in the home. Unlike many voice assistants relying on always-on and connected devices that are constantly listening for the wake word, the Voice Mate H1 remains in hibernation and only activates when it’s picked up by the user, maximizing privacy protection.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905190004/en/
Contacts
For Media Inquiries:
media@aqara.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release
Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom